Ir >>   
Uds: 0
Importe: 0,00
Tengo un usuario, deseo validarme - regístrate
  Buscar/Pesquisa        Búsqueda avanzada  
Herramienta de traducción gratuita de páginas web
Inicio/Iniciação
 > Libros de Medicina  > Neurología  > Neurogeriatría  - Llámanos (+34) 913788918 ¡Gasto de envío gratis para pedidos superiores a 50€ (sin iva) en Península!
Alzheimer's Disease, Targets For New Clinical Diagnostic And Therapeutic Strategies
Alzheimer s Disease, Targets For New Clinical Diagnostic And Therapeutic Strategies
Edición/Edição:
Autores: Renee D. Wegrzyn; Alan Rudolph
Editorial:
ISBN: 9781439827086
Formato: Rústica/Paperback
Nº volumenes: 1 Páginas: 298
Año publicación/Ano de publicação: 2012
Disponibilidad/Disponibilidade: 15 días
Precio/Preço : 136,30 € 129,49 € (134,67€ iva incluído)
 (Sea el primero en opinar ) ¿Vas a pedir más de 5 productos? Escríbenos, te enviaremos presupuesto ajustado, envíanos mail

Cómpralos juntos y ahorra
Alzheimer s Disease, Targets For New Clinical Diagnostic And Therapeutic Strategies Neurología en el anciano
· Alzheimer's Disease, Targets For New Clinical Diagnostic And Therapeutic Strategies (Renee D. Wegrzyn; Alan Rudolph)
· Neurología en el anciano (M. Fernandez | F. Micheli)
195,87 € 186,08 €
Descripción/Descrição
Key Features:
¡Provides an overview of the current status of Alzheimerfs disease with additional emphasis on other related neurodegenerative disorders
¡Examines molecular conformational changes in mechanisms of neurodegenerative disease
¡Discusses current small molecule and immunological approaches to Alzheimerfs therapeutics
¡Offers a preview of forthcoming clinical studies and therapeutics
In recent years, a tremendous amount of effort has been focused on better understanding the fundamentals of Alzheimerfs disease (AD) to facilitate early and accurate diagnosis and appropriately targeted therapeutic treatments. Alzheimerfs Disease: Targets for New Clinical, Diagnostic, and Therapeutic Strategies provides a detailed synopsis of the current state of the art of diagnostics and therapeutics and identifies emerging technologies and molecules that show promise in the management and treatment of AD. With contributions from experts drawn from academia, clinical practice, and the biotechnology and pharmaceutical industries, the book explores:

¡The basis of AD and the role of AƒÀ oligomers in development of disease
¡Existing and emerging in vitro biomarker-based methodologies for the diagnosis of AD, focusing on genetic, biochemical, and conformational strategies
¡In vivo imaging diagnostic approaches
¡Evolving diagnostic criteria, health regulatory guidelines, biomarkers in clinical trials, and available and emerging therapies
¡Recent progress in small-molecule disease-modifier drug discovery efforts for AD, specifically in the areas of AƒÀ, tau, and emerging neuroprotective/neurorepair approaches
¡How a case study of AD raises issues regarding clinical and pathologic criteria, risk factors, and the amyloid hypothesis
¡The molecular conformational factors that govern the pathogenicity of aggregating proteins, and how these factors could represent new targets for disease-modifying therapies
¡The latest epidemiological, pathological, biochemical, and behavioral studies that may shed some light on the risk of developing AD and similar dementias after traumatic brain injury
Examining current hypotheses and suggesting possible new approaches to therapeutic clinical applications, this volume paves the way for a robust pipeline of therapeutics to combat not only AD, but a whole host of other neurodegenerative diseases.

Audience: Clinical neurologists, researchers in neuroscience, primary care practitioners, pharmaceutical industry professionals, healthcare service providers, and health policy makers.

Contents:
¡The Amyloid ƒÀ-Protein and Alzheimerfs Disease.
¡Emerging Principles and Biomarkers in In Vitro Diagnostics for Alzheimerfs Disease.
¡Imaging Biomarkers for Diagnosis, Prognosis, and Treatment of Alzheimerfs Disease.
¡The Current Status of Alzheimerfs Disease Treatment: Why We Need Better Therapies and How We Will Develop Them.
¡New Small Molecule Drug Discovery for Alzheimerfs Disease.
¡Alzheimerfs Disease: Clinical Aspects.
¡Pathogenic Protein Strains as Diagnostic and Therapeutic Targets in Alzheimerfs Disease.
¡Traumatic Brain Injury in the Development of Alzheimerfs Disease: Risk Factors, Diagnosis, and Treatment Strategies.
Lo más vendido este mes/Os mais vendidos este mês
Manual de Neurocirugía 2Vols
Journal, 2013
M. Greenberg | Mark S. Greenberg
119,70 €
Neurología Pediátrica
Panamericana, 2007
Natalio Fejerman
100,71 €
Neurology Self-Assessment. A Companion To Bradley s Neurology In Clinical Practice (Online And Print)
Elsevier España, 2016
Justin T. Jordan | David R. Mayans | Michael J. Soileau
53,85 €
Manual De Neuropsicología 2Ed
Viguera, 2011
Fernando Maestú Unturbe | Marcos Ríos Lago | Javier Tirapu Ustarroz
65,84 €
La Afasia: Conocer para rehabilitar
Akadia, 2010
Anna Basso
27,81 €
Manual de logopedia (4ª ed.)
Elsevier España, 2013
Jordi Peña-Casanova
63,61 €
Rehabilitación Neuropsicológica. Estrategias En Trastornos De La Infancia Y Del Adulto
Manual Moderno, 2014
Martín Pérez Mendoza | Eduardo Alejandro Escotto Córdova | Juan Carlos Arango Lasprilla
27,81 €
Neurociencia. La Exploración Del Cerebro 4ª Ed.
Wolters Kluwer España, 2016
Mark F. Bear | Barry W. Connors | Michael A. Paradiso
88,78 €
Suscripciones
Si desea suscribirse a nuestros boletines gratuitos por favor regístrese como usuario.
Atención clientes
Para realizar sus pedidos o consultas relacionadas con productos llame al:
(+34)91 378 89 18





 

Acerca de los certificados SSL
Nosotros subscribimos Los Principios del código HONcode de la Fundación Salud en la Red Nosotros subscribimos los Principios del código HONcode. Compruébelo aquí.